Navigating Uncertain Waters: First-Trimester Screening’s Role in Identifying Neonatal Complications
Journal of Clinical Medicine · 29.03.2024 · 13 (7) · 1982
DOI: 10.3390/jcm13071982 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 29.03.2024. Verfasst von Grzegorz Swiercz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Collegium Medicum, Jan Kochanowski University in Kielce, Zeromskiego Street 5, 25-369 Kielce, Poland. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KOPIPOL Association’s Creators Fund.
Abstract (Originalsprache)
Background
Contemporary diagnostic methods aimed at assessing neonatal outcomes predominantly rely on the medical history of pregnant women. Ideally, universal biomarkers indicating an increased risk of delivering infants in poor clinical condition, with a heightened likelihood of requiring hospitalization in a Neonatal Intensive Care Unit (NICU), would be beneficial for appropriately stratifying pregnant women into a high-risk category. Our study evaluated whether biochemical and ultrasonographical markers universally used in first-trimester screenings for non-heritable chromosomal aberrations could serve this purpose.
Methods
This study encompassed 1164 patients who underwent first-trimester screening, including patient history, ultrasound examinations, and biochemical tests for pregnancy-associated plasma protein-A (PAPP-A) and the free beta-HCG subunit (fbHCG), from January 2019 to December 2021. The research concentrated on the correlation between these prenatal test results and neonatal outcomes, particularly Apgar scores, umbilical blood pH levels, and the necessity for NICU admission.
Results
In our cohort, neonates scoring lower than 8 on the Apgar scale at birth exhibited lower concentrations of PAPP-A in the first trimester, both in raw and normalized values (PAPP-A MoM 0.93 vs. 1.027, p = 0.032). We also observed a higher pulsatility index in the venous duct in the first trimester in full-term neonates born with
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Collegium Medicum, Jan Kochanowski University in Kielce, Zeromskiego Street 5, 25-369 Kielce, Poland.
- Clinic of Obstetrics and Gynecology, Provincial Combied Hospital in Kielce, Grunwaldzka 45, 25-736 Kielce, Poland.
ORCID-Profile: Anna Zmelonek-Znamirowska, Marta Mlodawska, Jakub Mlodawski
Förderung
- KOPIPOL Association’s Creators Fund
Zitieren
APA
Swiercz, G., Zmelonek-Znamirowska, A., Szwabowicz, K., Armanska, J., Detka, K., Mlodawska, M., & Mlodawski, J. (2024). Navigating Uncertain Waters: First-Trimester Screening’s Role in Identifying Neonatal Complications. Journal of Clinical Medicine, 13(7), 1982. https://doi.org/10.3390/jcm13071982
Vancouver
Swiercz G, Zmelonek-Znamirowska A, Szwabowicz K, Armanska J, Detka K, Mlodawska M, et al. Navigating Uncertain Waters: First-Trimester Screening’s Role in Identifying Neonatal Complications. Journal of Clinical Medicine. 2024;13(7):1982. doi:10.3390/jcm13071982
BibTeX
@article{Swiercz2024,
author = {Swiercz, Grzegorz and Zmelonek-Znamirowska, Anna and Szwabowicz, Karol and Armanska, Justyna and Detka, Karolina and Mlodawska, Marta and Mlodawski, Jakub},
title = {Navigating Uncertain Waters: First-Trimester Screening’s Role in Identifying Neonatal Complications},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {7},
pages = {1982},
doi = {10.3390/jcm13071982}
}
EUVIMED